Sight Diagnostics, an Israeli medical device startup specializing in rapid blood testing technology, laid off approximately 40 employees on May 9, 2024, representing about 30% of its 130-person workforce. This marks the company's second significant round of layoffs following a 2022 reorganization. The company, which has raised $124 million, cited the need to ensure financial strength amid a challenging macroeconomic environment in Israel and globally.
